| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $377.7M | +520.0% |
| R&D Expense | $437.4M | +40.4% |
| SG&A Expense | $116.8M | +33.0% |
| Operating Income | -$176.5M | +47.9% |
| Pre-tax Income | -$131.2M | +49.6% |
| Income Tax | $1.4M | -59.9% |
| Net Income | -$132.5M | +54.2% |
| EPS (Basic) | -$1.72 | +58.4% |
| EPS (Diluted) | -$1.72 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $435.9M | +87.3% |
| Current Assets | $1.21B | +10.8% |
| Total Assets | $1.46B | +8.8% |
| Current Liabilities | $205.6M | -8.1% |
| Total Liabilities | $478.4M | -21.3% |
| Stockholders' Equity | $981.3M | +33.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.2M | -762.3% |
| Capital Expenditures | $33.7M | -31.1% |
| Investing Cash Flow | $71.8M | +115.6% |
| Financing Cash Flow | $276.4M | +147.7% |
| Free Cash Flow | -$182.9M | -592.3% |
| +58.4% |